AbbVie Stock Rises. Earnings Beat, Guidance Raised But Trump Tariffs May Bite. - Barron's
1. AbbVie reported quarterly earnings above analyst expectations. 2. EPS was $2.46, exceeding forecasts of $2.38. 3. Sales reached $13.3 billion versus $12.9 billion expected. 4. Guidance for 2025 EPS raised to $12.09-$12.29. 5. Stock outperformed S&P 500, with a 1.5% year-to-date increase.